newsfilter
← Latest News
PR Newswire·

New Analysis Shows PrimeC Significantly Improves Key miRNAs in ALS Patients

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe...